H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure. Census population 255,205. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Laredo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Laredo storefront.
361 HCT/P Compliant Tissue Products in Laredo, TX for clinics & physicians. Exclusively 361 HCT/P complian… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Texas chart is a denial pattern. You are JH. CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure. Use Texas DSHS for community education; use the IFU for the product in the fridge. 361 hctp compliant products is the SKU conversation, not a patient appointment book.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)Three grains, kept separate on purpose. City: Census 255,205 and CDC PLACES crude rates. State: Texas DSHS, Diabetes Belt counties present. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Laredo trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 16.4% of adults — 4.4 points above the U.S. 12% figure. Obesity is 42.2%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Laredo trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JH reviewers and surveyors expect — not a brochure.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Bring specialty, monthly joint / regenerative volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 16.4% diabetes and 18.8% arthritis for Laredo — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Laredo, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Laredo is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Laredo — 4.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Laredo. Useful for joint-program math; still needs a diagnosis and privileging.
No Laredo storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.